| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |